Veracyte, Inc. (VCYT)
49.24
+1.97
(+4.17%)
USD |
NASDAQ |
Jun 09, 16:00
49.24
0.00 (0.00%)
After-Hours: 20:00
Veracyte SG&A Expense (Quarterly) : 50.84M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Arcturus Therapeutics Holdings, Inc. | 9.465M |
| Quantum Cyber NV | 2.404M |
| bioAffinity Technologies, Inc. | 3.242M |
| Ionis Pharmaceuticals, Inc. | 150.36M |
| Recursion Pharmaceuticals, Inc. | 34.59M |